PRAX Praxis Precision Medicines, Inc.
Healthcare$350.74+0.00%OpenMarket Cap: $7.42B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.04
P/S
0.00
EV/EBITDA
-19.07
DCF Value
$14.94
FCF Yield
-3.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-43.0%
ROA
-22.4%
ROIC
-25.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-105.9M | $-92.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-97.0M | $-88.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-326.2M | $-303.3M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-78.4M | $-73.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-76.1M | $-71.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-74.7M | $-69.3M | $— | — |
| Q4 null | $7.5M | -654.2% | $-64.0M | $-58.7M | $— | — |
| FY null | $8.6M | -1682.0% | $-200.2M | $-182.8M | $— | — |
| Q3 null | $302.0K | -13767.9% | $-56.8M | $-51.9M | $— | — |
| Q2 null | $357.0K | -7535.9% | $-37.5M | $-32.7M | $— | — |
| Q1 null | $431.0K | -6160.8% | $-41.9M | $-39.6M | $— | — |
| Q4 2023 | $515.0K | -3470.5% | $-27.8M | $-26.9M | $-2.97 | — |